Showing posts with label Viral Inactivation. Show all posts
Showing posts with label Viral Inactivation. Show all posts

Wednesday, 11 April 2018

Global Viral Inactivation Market To Expand At A Healthy 7.4% CAGR From 2017 To 2025 To Become Worth US$5.736 Bn

Researchmoz added Most up-to-date research on "Viral Inactivation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its huge collection of research reports.

Viral clearance study is one of the most important aspect for clinical trials, for manufacturing and commercialization of biopharmaceutical products derived from human and animal sources. Biologics products developed from human, plants and animal resources represents the higher levels of risk for viral contamination as these sources are known to carry number of human as well as other pathogenic viruses. Viral contamination of these biologics products used for treatment of variety of disease can have the several implications right from severe clinical complications to economic loss.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1339670

Viral clearance studies in large scale bio manufacturing process ensures the viral safety of biological products by screening the raw materials, testing the process intermediates and evaluates the capability and effectiveness of manufacturing process to achieve the desired level of viral safety of biologic products. Several methods have been developed and are currently practiced by the biopharmaceutical companies and other end users to ensure the viral safety of biologics products. The methods includes chemical method, radiation method and other methods such as pasteurization and dry & moist heat treatment.

Viral inactivation methods have broad applications in blood & blood components, vaccines production, cell & tissue culture products and other biologics products. These viral clearance method help maximize the production by establishing operational parameters at different stages without hampering product quality.

Global Viral Inactivation Market: Drivers

Rapid growth of biosimilars and biologics market in global biopharmaceutical industry, Regulatory compliances for viral inactivation of biologics products, and increasing number of new drugs approval are some of the key driving factors for the growth of global viral inactivation market during forecast period. In 2015, 51 drugs were approved out of which 45 drugs approved by Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) and 6 approved by Center for Biologics Evaluation and Research (CBER). Also In March 2015, the US FDA approved the first biosimilars product for marketing in the United States. Since then large number of biosimilars products have been filed for FDA clearance and many new applications are anticipated to be filed during forecast period.

It is estimated that more than US$ 100 Bn biologics products market will go off patent in next few years which will open the window for the biosimilars products market. This estimated growth in biosimilars market is projected to be key driving factor for global viral inactivation market. However the high cost of biologics and biosimilars products development and manufacturing and high cost of equipment for viral inactivation are likely to limit the growth of viral inactivation market during forecast period. Emergence of new viruses and development of vaccines against these viruses, development and adoption of newer viral inactivation methods and Growing application monoclonal antibodies and recombinant proteins for treatment of variety of diseases represents the new market opportunity for global viral inactivation market during forecast period.

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/viral-inactivation-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2025-report.html/toc

Global Viral Inactivation Market: Segmentation

Global viral inactivation market is broadly segmented in four segments on the basis of methods used for viral inactivation, by application, by end user and by region. Based on methods, viral inactivation market has been segmented into chemical methods, radiation method, and other methods of viral inactivation. Out of these methods, chemical method of viral inactivation dominated the market.  Chemical method is further sub-segmented into solvent detergent method, use of alkylating agent method and pH concentration method. The Solvent detergent method is projected to account largest market share by the end of 2025.

Chemical method is considered as the robust & efficient method for inactivation of variety of enveloped viruses. Also this method of viral inactivation is found to be economic, safer and delivers higher levels of purity of sample/ media. These advantages of chemical method have made the end user the first preference for viral inactivation. Radiation method for viral inactivation is projected to witness highest CAGR during forecast period owing to increased adoption of this method by most of blood center in developed countries.

By application, global viral inactivation market is segmented into blood and blood products, vaccines and cell & tissue culture products. Blood and blood products dominated the market due to high cost of viral inactivation per unit of blood and blood components, increasing demand for plasma and platelets for transfusion therapy globally. The end user of global viral inactivation market includes the pharmaceutical and biotechnology companies, blood banks & hospitals, contract research organizations and other end users.

Geographically, the global viral inactivation market is segmented into five regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. These regions have been further segmented by countries, methods, applications and end-users. North America dominated the market and is anticipated to lose its market share to Asia Pacific region by the end of 2025.

Global Viral Inactivation Market: Competitive Landscape

The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the global viral inactivation market. The report also profiles major players in the market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Major companies competing in the global viral inactivation market, and profiled in the report include Parker Hannifin Corporation, Merck & Co., Inc., Shandong Weigao Group Medical Polymer Company Limited, Sartorius AG, Cerus Corporation, Macopharma SA, Terumo BCT, Inc., Thermo Fisher Scientific Inc. and V.I.P.S. SA

Global Viral inactivation Market is segmented as given below:

Global Viral Inactivation Market, by Method

- Chemical Method
- Radiation Method
- Other Methods

Make an Enquiry of this report @ https://www.researchmoz.us/enquiry.php?type=E&repid=1339670

Global Viral Inactivation Market, by Application

- Blood & Blood Products
- Vaccines
- Cell & Tissue Culture

Global Viral Inactivation Market, by End-user

- Pharmaceutical & Biotechnology Companies
- Blood Banks & Hospitals
- Contract Research Organizations
- Other

Global Viral Inactivation Market, by Geography

- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa

Friday, 2 December 2016

Global and China Viral Inactivation Industry Analysis, Growth, Demand, Trend, Size, Share and Forecast Research Report 2020

Researchmoz added Most up-to-date research on "Global and China Viral Inactivation Research Report to 2020" to its huge collection of research reports.

This report studies Viral Inactivation in Global and China market, focuses on top manufacturers in global and China market, involving Viral Inactivation price of each type, production, revenue and market share for each manufacturer. This report also displays the production, revenue and market share of Viral Inactivation in USA, EU, China, Japan, India and Southeast Asia, forecast to 2020, from 2011.
The global viral inactivation market was valued at USD 320.5 Million in 2016 and poised to grow at a CAGR of 12.3% between 2016 and 2021, to reach USD 573.0 Million in 2021.

Split by product types, with production, revenue, market share and price of each type, as well as the types and price of each type price for each manufacturer in 2015 and 2016, through interviewing the key manufacturers, covering

Kits and Reagents Services
Viral Inactivation Systems and Accessories
Split by manufacturers, this report focuses on the production, price of each type, average price of Viral Inactivation, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering
Clean Cells
Charles River Laboratories International, Inc.
Danaher Corporation
Merck KGaA
Parker Hannifin
Rad Source Technologies
Sartorius AG
SGS S.A.
Texcell, Inc.
Viral Inactivated Plasma Systems SA
WuXi PharmaTech (Cayman) Inc.
Split by applications, this report focuses on consumption and growth rate of Viral Inactivation in each application, can be divided into
Blood & Blood Products
Cellular & Gene Therapy Products
Stem Cell Products
Tissue & Tissue Products
Vaccines and Therapeutics

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=750792

Split by regions, this report focuses on the production, revenue, consumption and market share of Viral Inactivation in these regions, from 2011 to 2020 (forecast), covering

USA
EU
Japan
China
India
Southeast Asia

Table of Contents
Global and China Viral Inactivation Research Report to 2020
1 Viral Inactivation Overview and Price  of Each Type
1.1 Product Overview and Scope of Viral Inactivation
1.2 Global and China Viral Inactivation Production, Growth Rate 2011 to 2020
1.3 Global and China Viral Inactivation Revenue, Growth Rate 2011 to 2020
1.4 Product Segments and Price of Each Type
1.4.1 Kits and Reagents and Price List (2015-2016)
1.4.2 Services and Price List (2015-2016)
1.4.3 Viral Inactivation Systems and Accessories and Price List (2015-2016)
1.5 Price List (Interviewed) of Each Type for Key Manufacturers in 2015 and 2016
1.5.1 Price List (Interviewed) of Kits and Reagents by Key Manufacturers
1.5.2 Price List (Interviewed) of Services by Key Manufacturers
1.5.3 Price List (Interviewed) of Viral Inactivation Systems and Accessories by Key Manufacturers
1.6 Global and China Viral Inactivation Market Share by Type in 2015
1.6.1 Global Viral Inactivation Market Share by Type in 2015
1.6.2 China Viral Inactivation Market Share by Type in 2015

2 Global and China Market Competition Analysis by Manufacturers
2.1 Global Market Viral Inactivation Production, Revenue and Share List of Key Manufacturers 2015 to 2016
2.1.1 Global Market Viral Inactivation Production and Share of Key Manufacturers 2015 to 2016
2.1.2 Global Market Viral Inactivation Revenue and Share of Key Manufacturers 2015 to 2016
2.1.3 Global Market Viral Inactivation Average Price of Key Manufacturers 2015 to 2016
2.2 China Market Viral Inactivation Production, Revenue and Share of Key Manufacturers 2015 to 2016
2.2.1 China Market Viral Inactivation Production and Share of Key Manufacturers 2015 to 2016
2.2.2 China Market Viral Inactivation Revenue and Share of Key Manufacturers 2015 to 2016
2.3 Global Viral Inactivation Manufacturing Base Distribution and Product Type of each Manufacturer

3 Global and China Viral Inactivation Production, Revenue and Growth Rate by Type
3.1 Global Viral Inactivation Production, Revenue and Growth Rate by Type (2011-2020)
3.1.1 Global Viral Inactivation Production and Market Share by Type (2011-2020)
3.1.2 Global Viral Inactivation Revenue and Market Share by Type (2011-2020)
3.1.3 Global Viral Inactivation Price by Type (2011-2020)
3.2 Global Viral Inactivation Production Growth Rate by Type (2011-2020)
3.2.1 Kits and Reagents Production and Production Growth Rate 2011-2020
3.2.2 Services Production and Production Growth Rate 2011-2020
3.2.3 Viral Inactivation Systems and Accessories Production and Production Growth Rate 2011-2020
3.3 China Viral Inactivation Production, Revenue and Growth Rate by Type (2011-2020)
3.3.1 China Viral Inactivation Production and Market Share by Type (2011-2020)
3.3.4 China Viral Inactivation Revenue and Market Share by Type (2011-2020)
3.3.3 China Viral Inactivation Price by Type (2011-2020)
3.4 China Viral Inactivation Production Growth Rate by Type (2011-2020)
3.4.1 Kits and Reagents Production and Production Growth Rate 2011-2020
3.4.2 Services Production and Production Growth Rate 2011-2020
3.4.3 Viral Inactivation Systems and Accessories Production and Production Growth Rate 2011-2020

4 Global and China Viral Inactivation Key Manufacturers Analysis
4.1 Clean Cells(FR)

4.1.1 Company Basic Information, Manufacturing Base and Competitors
4.1.2 Viral Inactivation Product Segment of Clean Cells by Type
4.1.2.1 Kits and Reagents and Price in 2015 and 2016 of Clean Cells
4.1.2.2 Services and Price in 2015 and 2016 of Clean Cells
4.1.2.3 Viral Inactivation Systems and Accessories and Price in 2015 and 2016 of Clean Cells
4.1.3 Viral Inactivation Production, Revenue, Price of Clean Cells 2015 to 2016
4.1.4 Interviewee, Name and Contact
4.2 Charles River Laboratories International, Inc.(US)
4.2.1 Company Basic Information, Manufacturing Base and Competitors
4.2.2 Viral Inactivation Product Segment of Charles River Laboratories International, Inc. by Type
4.2.2.1 Kits and Reagents and Price in 2015 and 2016 of Charles River Laboratories International, Inc.
4.2.2.2 Services and Price in 2015 and 2016 of Charles River Laboratories International, Inc.
4.2.2.3 Viral Inactivation Systems and Accessories and Price in 2015 and 2016 of Charles River Laboratories International, Inc.
4.2.3 Viral Inactivation Production, Revenue, Price of Charles River Laboratories International, Inc. 2015 to 2016
4.2.4 Interviewee, Name and Contact
4.3 Danaher Corporation (US)
4.3.1 Company Basic Information, Manufacturing Base and Competitors
4.3.2 Viral Inactivation Product Segment of Danaher Corporation by Type
4.3.2.1 Kits and Reagents and Price in 2015 and 2016 of Danaher Corporation
4.3.2.2 Services and Price in 2015 and 2016 of Danaher Corporation
4.3.2.3 Viral Inactivation Systems and Accessories and Price in 2015 and 2016 of Danaher Corporation
4.3.3 Viral Inactivation Production, Revenue, Price of Danaher Corporation 2015 to 2016
4.3.4 Interviewee, Name and Contact
4.4 Merck KGaA(DE)
4.4.1 Company Basic Information, Manufacturing Base and Competitors
4.4.2 Viral Inactivation Product Segment of Merck KGaA by Type
4.4.2.1 Kits and Reagents and Price in 2015 and 2016 of Merck KGaA
4.4.2.2 Services and Price in 2015 and 2016 of Merck KGaA
4.4.2.3 Viral Inactivation Systems and Accessories and Price in 2015 and 2016 of Merck KGaA
4.4.3 Viral Inactivation Production, Revenue, Price of Merck KGaA 2015 to 2016
4.4.4 Interviewee, Name and Contact
4.5 Parker Hannifin (US)
4.5.1 Company Basic Information, Manufacturing Base and Competitors
4.5.2 Viral Inactivation Product Segment of Parker Hannifin by Type
4.5.2.1 Kits and Reagents and Price in 2015 and 2016 of Parker Hannifin
4.5.2.2 Services and Price in 2015 and 2016 of Parker Hannifin
4.5.2.3 Viral Inactivation Systems and Accessories and Price in 2015 and 2016 of Parker Hannifin
4.5.3 Viral Inactivation Production, Revenue, Price of Parker Hannifin 2015 to 2016
4.5.4 Interviewee, Name and Contact

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=750792

Blood Thawing System Market Insights Shared in Detailed Report

Blood Thawing System Market: Introduction According to the report, the global  blood thawing system market  was valued at ~US$ 174 Mn in 2...